Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Greene, SJ; Gheorghiade, M; Borlaug, BA; Pieske, B; Vaduganathan, M; Burnett, JC; Roessig, L; Stasch, JP; Solomon, SD; Paulus, WJ; Butler, J.
The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.
J Am Heart Assoc. 2013; 2(6):e000536-e000536
Doi: 10.1161/JAHA.113.000536
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Pieske Burkert Mathias
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Cardiovascular Agents - therapeutic use
-
Cyclic GMP - metabolism
-
Drug Design -
-
Heart Failure - drug therapy
-
Humans -
-
Molecular Targeted Therapy -
-
Second Messenger Systems - drug effects
-
Stroke Volume -
-
Ventricular Function, Left - drug effects
- Find related publications in this database (Keywords)
-
cGMP
-
heart failure
-
phosphodiesterase 5
-
preserved ejection fraction
-
soluble guanylate cyclase